How have NVH shares performed in 2024?

Novoheart's stock was trading at C$0.53 on January 1st, 2024. Since then, NVH shares have increased by 0.0% and is now trading at C$0.53. View the best growth stocks for 2024 here .

What other stocks do shareholders of Novoheart own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novoheart investors own include Invitae (NVTA) and Natera (NTRA) .

How do I buy shares of Novoheart?

Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:NVH

Novoheart (NVH) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)

Free NVH Stock Alerts

C$0.53

+0.01 (+1.92%)

(As of 11/20/2020)

Compare

Today's Range: C$0.52
▼
C$0.53
50-Day Range: C$0.53
▼
C$0.53
52-Week Range: C$0.26
▼
C$0.72

Volume: 23,066 shs
Average Volume: 33,593 shs
Market Capitalization: C$99.98 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Novoheart alerts:

Ad Wall Street Star

This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

About Novoheart

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.

NVH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NVH Stock News Headlines

June 12, 2023 | finance.yahoo.com

067570.KQ - NVH Korea Inc.

February 21, 2023 | uk.investing.com

NVH Korea Inc (067570)

April 24, 2024 | GoldenCrest Metals (Ad)

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

July 22, 2021 | investing.com

Novoheart Holdings Inc (NVH)

See More Headlines

Receive NVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novoheart and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:NVH
CUSIP: N/A
CIK: N/A
Web: www.novoheart.com
Phone: 604-398 3170
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 27.62
Current Ratio: 6.13
Quick Ratio: 6.05

Sales & Book Value

Annual Sales: C$423,500.00
Price / Sales: 236.08
Cash Flow: C$0.07 per share
Price / Cash Flow: 7.46
Book Value: C$0.12 per share
Price / Book: 4.34

Miscellaneous

Outstanding Shares: 188,641,000
Free Float: N/A
Market Cap: C$99.98 million
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Ronald Li B.Sc. (Hons) (Age 49)
Ph.D., Scientific Co-Founder, CEO & Director
Comp: $295.17k
Dr. Camie Chan B.S. (Age 46)
B.Sc. (Hons), M.Sc., Ph.D., Interim CFO, COO, Corp. Sec. & Director
Comp: $312.03k
Prof. Kevin Costa B.S. (Age 54)
Ph.D., Chief Scientific Officer & Scientific Co-Founder
Prof. Michelle Khine
Scientific Co-Founder & Member of Scientific Advisory Board

Key Competitors

View All Competitors

NVH Stock Analysis - Frequently Asked Questions

How have NVH shares performed in 2024?: Novoheart's stock was trading at C$0.53 on January 1st, 2024. Since then, NVH shares have increased by 0.0% and is now trading at C$0.53.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Novoheart own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Novoheart investors own include Invitae (NVTA) and Natera (NTRA).
How do I buy shares of Novoheart?: Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:NVH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial